Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Oct-17 5:35 PM View:  | Hinrichs James F. Executive VP, CFO | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 72,230 | -- | -- | (100%) 72.23K to 0 | |
| 03-Oct-17 5:34 PM View: | Hargadon Robert Bernard SVP, Global Human Resources | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 26,190 | -- | -- | (100%) 26.19K to 0 | |
| 03-Oct-17 5:33 PM View: | Gladwell Mark Senior VP, Global Operations | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 9,791 | -- | -- | (100%) 9.79K to 0 | |
| 03-Oct-17 5:34 PM View: | Guerdan Melissa SVP, Global Quality & Reg. | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 16,385 | -- | -- | (100%) 16.39K to 0 | |
| 03-Oct-17 5:38 PM View: | McKillop Thomas Director | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 5,530 | -- | -- | (100%) 5.53K to 0 | |
| 03-Oct-17 5:36 PM View: | Levy John F Director | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 172,223 | -- | -- | (100%) 172.22K to 0 | |
| 03-Oct-17 5:39 PM View: | Powers Gregg J Director | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition Duplicate | 5,530 | -- | -- | (100%) 5.53K to 0 | |
| 03-Oct-17 5:36 PM View: | Malkani Sanjay Global Pres., Toxicology | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 565 | -- | -- | (100%) 0.56K to 0 | |
| 03-Oct-17 5:38 PM View: | Nawana Namal Chief Executive Officer Director | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 174,129 | -- | -- | (100%) 174.13K to 0 | |
| 03-Oct-17 5:32 PM View: | Cramp Daniella Global Pres., Cardiometabolic | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 28,298 | -- | -- | (99%) 28.57K to 0.28K | |
| 03-Oct-17 5:42 PM View: | Wygant Jonathan VP, Controller, CAO | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 1,909 | -- | -- | (100%) 1.91K to 0 | |
| 03-Oct-17 5:33 PM View: | Goldberg Carol R Director | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 40,614 | -- | -- | (48%) 85.21K to 44.6K | |
| 03-Oct-17 5:40 PM View: | Quelch John Director | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 26,651 | -- | -- | (100%) 26.65K to 0 | |
| 03-Oct-17 5:30 PM View: | Bridgen John Sr VP, Business Development | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 20,646 | -- | -- | (100%) 20.65K to 0 | |
| 03-Oct-17 5:37 PM View: | Markison Brian A Director | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 5,530 | -- | -- | (100%) 5.53K to 0 | |
| 03-Oct-17 5:31 PM View: | Chiniara Ellen GC, Chief Ethics Officer&Sec | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 32,764 | -- | -- | (100%) 32.76K to 0 | |
| 03-Oct-17 5:41 PM View: | Uppaluri Renuka Senior VP, Global R&D | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 13,267 | -- | -- | (100%) 13.27K to 0 | |
| 03-Oct-17 5:40 PM View: | Roosevelt James Jr. Director | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 9,974 | -- | -- | (100%) 9.97K to 0 | |
| 03-Oct-17 5:32 PM View: | Cramp Daniella Global Pres., Cardiometabolic | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 275 | -- | -- | (100%) 0.28K to 0 | |
| 03-Oct-17 5:32 PM View: | Ginsburg Geoffrey S Director | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 5,530 | -- | -- | (100%) 5.53K to 0 | |
| 03-Oct-17 5:33 PM View: | Goldberg Carol R Director | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 44,597 | -- | -- | (100%) 44.6K to 0 | |
| 03-Oct-17 5:39 PM View: | Powers Gregg J Director | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 46,000 | -- | -- | (89%) 51.53K to 5.53K | |
| 03-Oct-17 5:36 PM View: | Malkani Sanjay Global Pres., Toxicology | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 28,757 | -- | -- | (98%) 29.32K to 0.56K | |
| 03-Oct-17 5:39 PM View: | Pelossof Avi GlobalPres, Infectious Disease | Inverness Medical Innovatio... (ALR) | 03-Oct-17 | Disposition | 26,005 | -- | -- | (100%) 26.0K to 0 | |
| 05-Sep-17 7:42 PM View: | Gladwell Mark Senior VP, Global Operations | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Option Exercise | 5,000 | -- | -- | 70% 7.14K to 12.14K | |
| 05-Sep-17 7:31 PM View: | Pelossof Avi GlobalPres, Infectious Disease | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Option Exercise | 6,667 | -- | -- | 31% 21.8K to 28.47K | |
| 05-Sep-17 7:43 PM View: | Chiniara Ellen GC, Chief Ethics Officer&Sec | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Payment of Exercise | 2,163 | $49.46 | $106,982.00 | (6%) 34.93K to 32.76K | |
| 05-Sep-17 7:32 PM View: | Malkani Sanjay Global Pres., Toxicology | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Option Exercise | 6,667 | -- | -- | 27% 24.69K to 31.36K | |
| 05-Sep-17 7:40 PM View: | Hargadon Robert Bernard SVP, Global Human Resources | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Payment of Exercise | 1,823 | $49.46 | $90,165.60 | (7%) 28.01K to 26.19K | |
| 05-Sep-17 7:43 PM View: | Bridgen John Sr VP, Business Develop | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Payment of Exercise | 1,879 | $49.46 | $92,935.30 | (8%) 22.52K to 20.65K | |
| 05-Sep-17 7:32 PM View: | Malkani Sanjay Global Pres., Toxicology | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Payment of Exercise | 2,038 | $49.46 | $100,799.00 | (6%) 31.36K to 29.32K | |
| 05-Sep-17 7:31 PM View: | Pelossof Avi GlobalPres, Infectious Disease | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Payment of Exercise | 2,464 | $49.46 | $121,869.00 | (9%) 28.47K to 26.0K | |
| 05-Sep-17 7:43 PM View: | Chiniara Ellen GC, Chief Ethics Officer&Sec | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Option Exercise | 6,667 | -- | -- | 24% 28.26K to 34.93K | |
| 05-Sep-17 7:40 PM View: | Hargadon Robert Bernard SVP, Global Human Resources | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Option Exercise | 6,667 | -- | -- | 31% 21.35K to 28.01K | |
| 05-Sep-17 7:41 PM View: | Guerdan Melissa SVP, Global Quality & Reg. | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Payment of Exercise | 3,131 | $49.46 | $154,859.00 | (16%) 19.52K to 16.39K | |
| 05-Sep-17 7:51 PM View: | Cramp Daniella Global Pres., Cardiometabolic | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Option Exercise | 16,667 | $28.88 | $481,400.00 | 69% 24.16K to 40.83K | |
| 05-Sep-17 7:43 PM View: | Bridgen John Sr VP, Business Develop | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Option Exercise | 5,000 | -- | -- | 29% 17.52K to 22.52K | |
| 05-Sep-17 7:41 PM View: | Guerdan Melissa SVP, Global Quality & Reg. | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Option Exercise | 8,334 | -- | -- | 75% 11.18K to 19.52K | |
| 05-Sep-17 7:51 PM View: | Cramp Daniella Global Pres., Cardiometabolic | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Payment of Exercise | 12,254 | $49.46 | $606,083.00 | (30%) 40.83K to 28.57K | |
| 05-Sep-17 7:42 PM View: | Gladwell Mark Senior VP, Global Operations | Inverness Medical Innovatio... (ALR) | 31-Aug-17 | Payment of Exercise | 2,350 | $49.46 | $116,231.00 | (19%) 12.14K to 9.79K | |
| 05-Jul-17 9:14 PM View: | Levy John F Director | Inverness Medical Innovatio... (ALR) | 30-Jun-17 | Option Exercise | 5,530 | -- | -- | 3% 166.69K to 172.22K | |
| 05-Jul-17 9:06 PM View: | Roosevelt James Jr. Director | Inverness Medical Innovatio... (ALR) | 30-Jun-17 | Option Exercise | 5,530 | -- | -- | 124% 4.44K to 9.97K | |
| 05-Jul-17 9:09 PM View: | Ginsburg Geoffrey S Director | Inverness Medical Innovatio... (ALR) | 30-Jun-17 | Option Exercise | 5,530 | -- | -- | 100% 0 to 5.53K | |
| 05-Jul-17 9:11 PM View: | McKillop Thomas Director | Inverness Medical Innovatio... (ALR) | 30-Jun-17 | Option Exercise | 5,530 | -- | -- | 100% 0 to 5.53K | |
| 05-Jul-17 9:11 PM View: | Powers Gregg J Director | Inverness Medical Innovatio... (ALR) | 30-Jun-17 | Option Exercise Duplicate | 5,530 | -- | -- | 9% 64.61K to 70.14K | |
| 05-Jul-17 9:15 PM View: | Goldberg Carol R Director | Inverness Medical Innovatio... (ALR) | 30-Jun-17 | Option Exercise | 5,530 | -- | -- | 7% 79.68K to 85.21K | |
| 05-Jul-17 9:07 PM View: | Quelch John Director | Inverness Medical Innovatio... (ALR) | 30-Jun-17 | Option Exercise | 5,530 | -- | -- | 26% 21.12K to 26.65K | |
| 05-Jul-17 9:13 PM View: | Markison Brian A Director | Inverness Medical Innovatio... (ALR) | 30-Jun-17 | Option Exercise | 5,530 | -- | -- | 100% 0 to 5.53K | |
| 10-Apr-17 6:18 PM View: | Hinrichs James F. Executive VP, CFO | Inverness Medical Innovatio... (ALR) | 06-Apr-17 | Option Exercise | 16,667 | -- | -- | 30% 55.56K to 72.23K | |
| 02-Mar-17 6:08 PM View: | Uppaluri Renuka Senior VP, Global R&D | Inverness Medical Innovatio... (ALR) | 28-Feb-17 | Payment of Exercise | 2,505 | $38.30 | $95,941.50 | (16%) 15.77K to 13.27K |
